Investing Ideas
/
Swedish Pharmaceuticals & Biotech Top Stock Picks from Analysts

Swedish Pharmaceuticals & Biotech Top Stock Picks from Analysts

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are more than 50% undervalued based on analyst price target.

48 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
BIOA B BioArctic	SEK 195.90	-7.6%	-19.4%	SEK 17.3b	SEK 322.00	PS103.6x	E51.3%	0%
HNSA Hansa Biopharma	SEK 33.58	-15.6%	-0.5%	SEK 2.3b	SEK 101.40	PS12x	E46.5%	n/a
VICO Vicore Pharma Holding	SEK 9.27	-1.4%	-34.4%	SEK 2.2b	SEK 34.03	PS20.9x	E44.9%	n/a
EGTX Egetis Therapeutics	SEK 5.90	-14.0%	-1.7%	SEK 2.1b	SEK 11.50	PS31.2x	E97.3%	n/a
BICO BICO Group	SEK 28.70	-12.6%	-44.9%	SEK 2.0b	SEK 100.00	PS0.9x	E130.2%	n/a
BINV BioInvent International	SEK 30.50	-26.5%	78.8%	SEK 2.0b	SEK 90.00	PS51.9x	E108.6%	n/a
DMYD B Diamyd Medical	SEK 18.16	0.9%	124.8%	SEK 1.9b	SEK 40.00	PS14540.3x	E-10.3%	n/a
GENO Genovis AB (publ.)	SEK 24.10	1.9%	-52.3%	SEK 1.6b	SEK 39.00	PE56.5x	E16.4%	n/a
XSPRAY Xspray Pharma	SEK 30.40	-29.3%	-14.8%	SEK 1.1b	SEK 55.50	PB1.9x	E107.5%	n/a
CINPHA Cinclus Pharma Holding	SEK 19.52	-14.7%	n/a	SEK 908.6m	SEK 63.67	PB1.5x	E-33.0%	n/a
SANION Saniona	SEK 6.40	-9.3%	123.8%	SEK 716.1m	SEK 11.00	PS26.9x	S38.0%	n/a
FLUO FluoGuide	SEK 44.95	-13.6%	-32.1%	SEK 612.2m	SEK 133.73	PS342.4x	E55.1%	n/a
IRLAB A IRLAB Therapeutics	SEK 9.30	-21.8%	-21.5%	SEK 482.4m	SEK 56.07	PS9.5x	E23.5%	n/a
IMMU Mendus	SEK 8.22	-2.7%	-10.4%	SEK 414.0m	SEK 27.00	PS59.6x	E-15.3%	n/a
INIT Initiator Pharma	SEK 7.15	-3.4%	-20.9%	SEK 401.4m	SEK 22.50	n/a	E0.2%	n/a
ENZY Enzymatica	SEK 1.70	5.6%	-51.2%	SEK 366.8m	SEK 3.07	PS8.3x	E1.8%	n/a
MVIR Medivir	SEK 2.92	-8.2%	10.4%	SEK 327.5m	SEK 20.73	PS46.6x	E47.5%	n/a
ONCO Oncopeptides	SEK 1.50	-4.1%	-78.0%	SEK 323.6m	SEK 2.73	PS12x	E35.8%	n/a
CANTA Cantargia	SEK 1.70	1.1%	-50.5%	SEK 312.3m	SEK 8.33	PB6.4x	E-3.4%	n/a
ALZ Alzinova	SEK 3.30	0%	13.0%	SEK 294.2m	SEK 6.50	PS16.9x	E-39.4%	n/a
ACE Ascelia Pharma	SEK 2.92	-1.5%	-54.5%	SEK 280.1m	SEK 8.25	PB2.6x	E47.2%	n/a
KDEV Karolinska Development	SEK 1.00	-4.4%	-42.2%	SEK 269.3m	SEK 2.40	PS143.4x	E5.8%	n/a
ANNX Annexin Pharmaceuticals	SEK 0.48	1.3%	66.0%	SEK 254.8m	SEK 1.70	PB10.2x	E113.9%	n/a
GUARD Guard Therapeutics International	SEK 20.00	0.5%	-31.0%	SEK 245.9m	SEK 60.00	PB3.9x	E-8.1%	n/a

Page 1 of 2